Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions

scientific article published on 24 October 2017

Applying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S40471-017-0126-8
P932PMC publication ID5844483
P698PubMed publication ID29531893

P50authorLori C SakodaQ89685276
P2093author name stringLouise M Henderson
Hormuzd A Katki
Karen J Wernli
Tanner J Caverly
P2860cites workLung cancer screeningQ83394751
Prognosis and prognostic research: validating a prognostic modelQ83939735
A nomogram for predicting the risk of invasive pulmonary adenocarcinoma for patients with solitary peripheral subsolid nodulesQ88746735
Predicting Malignant Nodules from Screening CTsQ88804005
Lung cancer susceptibility model based on age, family history and genetic variantsQ21091204
Benefits and harms of CT screening for lung cancer: a systematic reviewQ24600624
Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesQ27025828
Reduced lung-cancer mortality with low-dose computed tomographic screeningQ28241954
A gene-based risk score for lung cancer susceptibility in smokers and ex-smokersQ28259916
The meaning and use of the area under a receiver operating characteristic (ROC) curveQ29547182
American Cancer Society lung cancer screening guidelinesQ30414481
Existing general population models inaccurately predict lung cancer risk in patients referred for surgical evaluationQ30417598
Pro-surfactant protein B as a biomarker for lung cancer prediction.Q30560535
Probability of cancer in pulmonary nodules detected on first screening CT.Q30573941
Predicting lung cancer prior to surgical resection in patients with lung nodulesQ30610197
Assessing the generalizability of prognostic informationQ33540894
Assessment of the cancer risk factors of solitary pulmonary nodulesQ33710108
Development and validation of a lung cancer risk prediction model for African-AmericansQ33788556
An expanded risk prediction model for lung cancerQ33788568
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodulesQ33900761
Recent methods for polygenic analysis of genome-wide data implicate an important effect of common variants on cardiovascular disease riskQ34059030
Comparison of discriminatory power and accuracy of three lung cancer risk modelsQ34059668
Variations in lung cancer risk among smokers.Q34184504
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer ScQ34308138
Screening for lung cancer: U.S. Preventive Services Task Force recommendation statementQ34394907
A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodulesQ34433475
Prediction of lung cancer risk in a Chinese population using a multifactorial genetic modelQ34507724
Decision curve analysis: a novel method for evaluating prediction modelsQ34581068
Individualized risk prediction model for lung cancer in Korean menQ34585888
Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohortsQ34611247
A risk model for lung cancer incidenceQ34966064
Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factorsQ35036257
Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.Q35090585
Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort studyQ35204017
A simple model for predicting lung cancer occurrence in a lung cancer screening program: The Pittsburgh PredictorQ35688591
The cytokinesis-blocked micronucleus assay as a strong predictor of lung cancer: extension of a lung cancer risk prediction modelQ35805572
Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodulesQ36254492
Risk prediction models for selection of lung cancer screening candidates: A retrospective validation studyQ36334146
Development and validation of clinical diagnostic models for the probability of malignancy in solitary pulmonary nodules.Q36439356
Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.Q36443729
The LLP risk model: an individual risk prediction model for lung cancerQ36614749
Role of selected genetic variants in lung cancer risk in African AmericansQ36759166
Screen-detected subsolid pulmonary nodules: long-term follow-up and application of the PanCan lung cancer risk prediction modelQ36839292
Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer ScreeningQ36984154
Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction modelQ36992197
Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation studyQ37045787
Targeting of low-dose CT screening according to the risk of lung-cancer deathQ37198867
Personalized Risk Assessment in Never, Light, and Heavy Smokers in a prospective cohort in TaiwanQ37386375
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsQ37513339
Selection criteria for lung-cancer screeningQ37594556
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodulesQ37615194
Application of risk prediction models to lung cancer screening: a review.Q38360276
Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOm2012 risk prediction toolQ38935397
The Vancouver Lung Cancer Risk Prediction Model: Assessment by Using a Subset of the National Lung Screening Trial CohortQ38980508
Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort StudyQ39016863
A retrospective validation study of three models to estimate the probability of malignancy in patients with small pulmonary nodules from a tertiary oncology follow-up centre.Q39138531
A Novel Pathway-Based Approach Improves Lung Cancer Risk Prediction Using Germline Genetic VariationsQ39738163
External validation is necessary in prediction research: a clinical exampleQ40549827
A Modified Model for Preoperatively Predicting Malignancy of Solitary Pulmonary Nodules: An Asia Cohort StudyQ40875701
Risk of malignancy in pulmonary nodules: A validation study of four prediction modelsQ41086632
Predictive Accuracy of the PanCan Lung Cancer Risk Prediction Model -External Validation based on CT from the Danish Lung Cancer Screening TrialQ41237900
An individual risk prediction model for lung cancer based on a study in a Chinese populationQ41376066
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelinesQ41581111
Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC CohortQ41668094
Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians (ACCP) evidence-based clinical practice guidelinesQ41903827
Incorporation of a genetic factor into an epidemiologic model for prediction of individual risk of lung cancer: the Liverpool Lung ProjectQ44506470
Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese peopleQ45232932
Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans.Q45331818
Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomographyQ46763864
LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer IncidenceQ47716360
The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.Q50958688
Analysis and validation of probabilistic models for predicting malignancy in solitary pulmonary nodules in a population in Brazil.Q51300743
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement.Q53162511
Development and validation of diagnostic prediction model for solitary pulmonary nodules.Q53454867
Calibration of Risk Prediction ModelsQ57238751
Incremental Value of Pulmonary Function and Sputum DNA Image Cytometry in Lung Cancer Risk PredictionQ57895945
Blood Pressure and Risk of Cancer Incidence and Mortality in the Metabolic Syndrome and Cancer ProjectQ58813381
A risk model for prediction of lung cancerQ80242314
Validation of a model of lung cancer risk prediction among smokersQ83276607
P433issue4
P304page(s)307-320
P577publication date2017-10-24
P1433published inCurrent epidemiology reportsQ27725586
P1476titleApplying Risk Prediction Models to Optimize Lung Cancer Screening: Current Knowledge, Challenges, and Future Directions
P478volume4

Reverse relations

Q64098201Lung cancer screening and shared decision making in cancer survivors: the long and winding roadcites workP2860

Search more.